| Soryal A Soryal, MD | |
|
1020 N 12th St, 3rd Floor, Milwaukee, WI 53233-1308 | |
| (414) 219-7300 | |
| Not Available |
| Full Name | Soryal A Soryal |
|---|---|
| Gender | Male |
| Speciality | Geriatric Medicine |
| Experience | 28 Years |
| Location | 1020 N 12th St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003882994 | NPI | - | NPPES |
| 34735800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 49824 (Wisconsin) | Primary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 35. 081392 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Allis Memorial Hospital | West allis, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Although more than half of the country's women will have some type of pelvic surgery and are therefore at risk for surgical adhesions, a survey released this month by the not-for- profit National Women's Health Resource Center (NWHRC) finds that women are largely unaware of the health risks associated with adhesions.
Lumeris, a leader in provider performance management technology and services for the health care industry, today announced the general market release of its innovative technology platform that helps health plans and other health care delivery organizations reduce the cost and improve the quality of care delivered to consumers.
Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.
Genzyme Corporation today announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule.
Inhaled nitric oxide (iNO), a therapy used in the treatment of premature newborns with respiratory failure that had shown promising results in short-term studies, does not significantly improve long-term outcomes, according to a national study led by critical care researchers at the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC.
› Verified 7 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Although more than half of the country's women will have some type of pelvic surgery and are therefore at risk for surgical adhesions, a survey released this month by the not-for- profit National Women's Health Resource Center (NWHRC) finds that women are largely unaware of the health risks associated with adhesions.
Lumeris, a leader in provider performance management technology and services for the health care industry, today announced the general market release of its innovative technology platform that helps health plans and other health care delivery organizations reduce the cost and improve the quality of care delivered to consumers.
Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.
Genzyme Corporation today announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule.
Inhaled nitric oxide (iNO), a therapy used in the treatment of premature newborns with respiratory failure that had shown promising results in short-term studies, does not significantly improve long-term outcomes, according to a national study led by critical care researchers at the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC.
› Verified 7 days ago
| Entity Name | Aurora Health Care Metro Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861447179 PECOS PAC ID: 8628986536 Enrollment ID: O20040114000498 |
News Archive
Although more than half of the country's women will have some type of pelvic surgery and are therefore at risk for surgical adhesions, a survey released this month by the not-for- profit National Women's Health Resource Center (NWHRC) finds that women are largely unaware of the health risks associated with adhesions.
Lumeris, a leader in provider performance management technology and services for the health care industry, today announced the general market release of its innovative technology platform that helps health plans and other health care delivery organizations reduce the cost and improve the quality of care delivered to consumers.
Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.
Genzyme Corporation today announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule.
Inhaled nitric oxide (iNO), a therapy used in the treatment of premature newborns with respiratory failure that had shown promising results in short-term studies, does not significantly improve long-term outcomes, according to a national study led by critical care researchers at the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Soryal A Soryal, MD 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233-1308 Ph: (414) 219-7300 | Soryal A Soryal, MD 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233-1308 Ph: (414) 219-7300 |
News Archive
Although more than half of the country's women will have some type of pelvic surgery and are therefore at risk for surgical adhesions, a survey released this month by the not-for- profit National Women's Health Resource Center (NWHRC) finds that women are largely unaware of the health risks associated with adhesions.
Lumeris, a leader in provider performance management technology and services for the health care industry, today announced the general market release of its innovative technology platform that helps health plans and other health care delivery organizations reduce the cost and improve the quality of care delivered to consumers.
Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.
Genzyme Corporation today announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule.
Inhaled nitric oxide (iNO), a therapy used in the treatment of premature newborns with respiratory failure that had shown promising results in short-term studies, does not significantly improve long-term outcomes, according to a national study led by critical care researchers at the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC.
› Verified 7 days ago
Julia Bonner, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 3351 North Downer Avenue, Milwaukee, WI 53211 Phone: 414-229-5684 | |
Dr. Zachary Smith, DO Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6830 Fax: 414-955-6214 | |
Dr. Christopher Patrick Boyd, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6000 Fax: 414-805-6280 | |
Umair Bajwa, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812 Fax: 414-805-0855 | |
Dr. Jeffrey Wilson, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, Ste 206, Milwaukee, WI 53233 Phone: 414-219-7136 | |
Rasika Surajyam Chepuri, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-7040 Fax: 414-955-6211 |